Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NCAB GROUP AB | XB1 | 8. oct 2024 | 5.05 | +1.51 |
NCC B | NCGB | 8. oct 2024 | 15.05 | +2.03 |
NCC Group | NZB | 8. oct 2024 | 1.95 | -2.50 |
NCI | NCL | 8. oct 2024 | 3.06 | -24.26 |
Ncino | 6NCA | 8. oct 2024 | 27.40 | -2.84 |
NCR Corporation | NCR1 | 8. oct 2024 | 12.20 | -1.61 |
NCS Multistage Holdings, Inc. | MUH0 | 8. oct 2024 | 15.90 | -4.79 |
ND PAPER | N3Y | 8. oct 2024 | 0.42 | -14.05 |
NE ELECTRIC | NE4H | 8. oct 2024 | 0.02 | -11.11 |
NEC Corporation | NEC1 | 8. oct 2024 | 83.66 | -1.69 |
Nedap (Nederlandsche Apparatenf) NV | NE3 | 8. oct 2024 | 57.00 | +1.42 |
Nedbank Group Ltd. | NCO | 8. oct 2024 | 15.10 | +0.67 |
NEDERMAN HLDG AB | 5QR | 8. oct 2024 | 19.90 | +1.22 |
Neinor Homes | 1NN | 8. oct 2024 | 15.14 | +0.80 |
Nekkar | 0TT | 8. oct 2024 | 0.75 | -0.80 |
Nektar Therapeutics | ITH | 8. oct 2024 | 1.15 | -3.05 |
NEL | D7G | 8. oct 2024 | 0.39 | -5.04 |
Nel ASA Unsponsored ADR (Norway) | D7GA | 8. oct 2024 | 11.20 | -0.89 |
Nelly Group | CD20 | 8. oct 2024 | 2.10 | -2.33 |
Nelnet, Inc. | NIJ | 8. oct 2024 | 101.00 | -0.98 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | 8. oct 2024 | 17.60 | -2.76 |
Nemetschek SE | NEM | 8. oct 2024 | 94.95 | +0.16 |
NENT Group B | NEB | 8. oct 2024 | 0.06 | +3.88 |
Neo Performance Materials Inc | N14 | 8. oct 2024 | 5.20 | -0.95 |
NEO-NEON | N2L | 8. oct 2024 | 0.04 | -3.51 |
Neodecortech S.p.a. | FM2 | 8. oct 2024 | 3.04 | +1.33 |
Neoen S.A. | N1N | 8. oct 2024 | 38.96 | +0.21 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | 8. oct 2024 | 11.10 | 0.00 |
Neogen Corporation | NG2 | 8. oct 2024 | 13.40 | -1.47 |
NeoGenomics, Inc. | NG9 | 8. oct 2024 | 12.40 | -1.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.